tipo
- journal article
Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer
Documento
- doi:10.31744/einstein_journal/2022gs6655
- http://dx.doi.org/10.31744/einstein_journal/2022GS6655
- http://dx.doi.org/10.31744/einstein_journal/2022gs6655
- http://https://journal.einstein.br/pt-br/article/cost-effectiveness-analysis-of-ado-trastuzumab-emtansine-for-the-treatment-of-residual-invasive-her2-positive-breast-cancer/][doi:10.31744/einstein_journal/2022gs6655
- Visão geral
- Pesquisas
- Identidade
- Informação adicional documento
- Outro
- Ver todos